CIK 0001661181 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 564.2 M | 450.9 M | ||
| Net income (USD) | 17.2 M | -38.7 M | ||
| Diluted EPS (USD/shares) | 0.15 | 0.12 |
Forms on file (last 1,000): 4 271, 8-K 108, 3 38, 10-Q 30, SC 13G/A 19, 425 16, SC 13G 15, CORRESP 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ORGO (0.002 USD), /gw/filings/filings?ticker=ORGO&form=8-K, /gw/filings/facts?ticker=ORGO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange